Open AccessSmoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease
Author(s) -
Jeffrey S. Berger,
Deepak L. Bhatt,
Steven R. Steinhubl,
Mingyuan Shao,
Philippe Gabríel Steg,
Gilles Montalescot,
Werner Hacke,
Keith A.A. Fox,
A. Michael Lincoff,
Eric J. Topol,
Peter B. Berger
Publication year - 2009
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.109.866533
Subject(s) - medicine , clopidogrel , disease , cardiology , atherosclerotic cardiovascular disease , aspirin
Smoking increases platelet aggregability and the degree of platelet inhibition by clopidogrel on ex vivo platelet function tests. Whether smoking status affects the relationship between clopidogrel and clinical outcomes is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom